Repeated Rectal SHIVSF162P3 Exposures Do Not Consistently Induce Sustained T Cell Responses Prior to Systemic Infection in the Repeat-Low Dose Preclinical Macaque Model

No abstract is available for this paper.

• Publication year

  2009

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/aid.2008.0287PMID 19689194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systemic and mucosal immunological responses during repeated mucosal SHIV(162P3) challenges prior to and following infection in pigtailed macaques.

  2008cited by this paper
• Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques.

  2008cited by this paper
• Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir

  2008cited by this paper
• Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3).

  2007cited by this paper
• No Evidence for Consistent Virus-Specific Immunity in Simian Immunodeficiency Virus-Exposed, Uninfected Rhesus Monkeys

  2007cited by this paper
• Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

  2007cited by this paper
• Establishing Acceptance Criteria for Cell-Mediated-Immunity Assays Using Frozen Peripheral Blood Mononuclear Cells Stored under Optimal and Suboptimal Conditions

  2007cited by this paper
• Preventing sexual transmission of HIV.

  2007cited by this paper
• Characterization of CD8+ T‐cell responses in HIV‐1‐exposed seronegative commercial sex workers from Nairobi, Kenya

  2006cited by this paper
• Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.

  2006cited by this paper
• HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.

  2006cited by this paper
• Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.

  2005cited by this paper
• Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients

  2005cited by this paper
• Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges

  2005cited by this paper
• A Period of Transient Viremia and Occult Infection Precedes Persistent Viremia and Antiviral Immune Responses during Multiple Low-Dose Intravaginal Simian Immunodeficiency Virus Inoculations

  2004cited by this paper
• Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells 1

  2003cited by this paper
• Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.

  2003cited by this paper
• Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.

  2003cited by this paper
• Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men

  2003cited by this paper
• Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals

  2003cited by this paper
• HIV preferentially infects HIV-specific CD4+ T cells

  2002cited by this paper
• HIV-1 and AIDS: what are protective immune responses?

  2002cited by this paper
• Mucosal Transmission and Induction of Simian AIDS by CCR5-Specific Simian/Human Immunodeficiency Virus SHIVSF162P3

  2001cited by this paper
• HIV versus the immune system: another apparent victory for the virus.

  2001cited by this paper
• New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.

  2001cited by this paper
• CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.

  2001cited by this paper
• Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

  1999cited by this paper
• Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa.

  1999cited by this paper
• Administration of 9-[2-(Phosphonomethoxy)propyl] adenine (PMPA) for Prevention of Perinatal Simian Immunodeficiency Virus Infection in Rhesus Macaques

  1998cited by this paper
• Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.

  1998cited by this paper
• Occult Systemic Infection and Persistent Simian Immunodeficiency Virus (SIV)-Specific CD4+-T-Cell Proliferative Responses in Rhesus Macaques That Were Transiently Viremic after Intravaginal Inoculation of SIV

  1998cited by this paper
• Silent Infection of Macaques Inoculated with Low-Dose SIVmac251/spl

  1997cited by this paper
• Protective immunity against HIV infection: has nature done the experiment for us?

  1996cited by this paper
• Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia

  1996cited by this paper
• Immune responses in HIV-exposed seronegatives: have they repelled the virus?

  1995cited by this paper
• Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome.

  1995cited by this paper
• Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia

  1994cited by this paper
• No Evidence of Occult SHIV Infection as Demonstrated by CD8 (cid:2) Cell Depletion after Chemoprophylaxis-Induced Protection from Mucosal Infection in Rhesus Macaques

  year unknowncited by this paper

• A threshold delay model of HIV infection of newborn infants through breastfeeding

  2019cites this paper
• Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation

  2015cites this paper
• Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses

  2015cites this paper
• Short communication: a repeated simian human immunodeficiency virus reverse transcriptase/herpes simplex virus type 2 cochallenge macaque model for the evaluation of microbicides.

  2014cites this paper
• Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.

  2014cites this paper
• Development of a rectal sexually transmitted infection – HIV coinfection model utilizing Chlamydia trachomatis and SHIVSF162p3

  2014cites this paper
• Susceptibility to Repeated, Low-Dose, Rectal SHIVSF162P3 Challenge Is Independent of TRIM5 Genotype in Rhesus Macaques

  2013cites this paper
• Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.

  2012cites this paper
• Simian-Human Immunodeficiency Viruses and Their Impact on Non-Human Primate Models for AIDS

  2012cites this paper
• Reduced In fl ammation and CD 4 Loss in Acute SHIV Infection During Oral Pre-Exposure Prophylaxis

  2012cites this paper
• T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis

  2011cites this paper
• AIDS Vaccines and Preexposure Prophylaxis: Is Synergy Possible?

  2011cites this paper
• Natural Substrate Concentrations Can Modulate the Prophylactic Efficacy of Nucleotide HIV Reverse Transcriptase Inhibitors

  2011cites this paper
• Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective

  2010cites this paper
• Resistance to Simian HIV Infection Is Associated With High Plasma Interleukin-8, RANTES and Eotaxin in a Macaque Model of Repeated Virus Challenges

  2010cites this paper
• [Application studies of animal models in evaluating safety and efficacy of HIV-1 microbicides].

  2010cites this paper
• Current World Literature

  2006cites this paper